Chronic News and Research

RSS

Second-hand smoke triggers complex inflammatory response

Second-hand smoke is associated with a number of diseases and conditions, including cancer, heart disease, and emphysema. It is an irritant to lung tissue and blood vessels, but the processes through which the body reacts to second-hand smoke comprise a mystery scientists are only beginning to unravel. Researchers at the University of Colorado-Denver are currently studying how second-hand smoke affects the lungs of rats, and so far it appears that second-hand smoke triggers a complex inflammatory response.

27 Aug 2010

Luminex launches FDA-cleared xTAG Cystic Fibrosis 60 Kit v2 diagnostic test

Luminex Corporation, the worldwide leader in multiplexed solutions, today announced the full commercial launch of its xTAG Cystic Fibrosis 60 Kit v2, a new diagnostic test that can simultaneously screen a single blood sample for up to 60 cystic fibrosis-causing genetic mutations in a matter of hours.

From Thermo Fisher Scientific Inc. 27 Aug 2010

Wall Street Journal reports on pharma's growing interest in emerging markets

Abbott Laboratories will soon acquire the biggest share of India's pharmaceuticals market, about 7%, when the company closes as early as next month on a $3.7 billion takeover of the drugs business of Piramal Healthcare Ltd

27 Aug 2010

Researchers recommend traumatic brain injury reclassification for additional funding

Traumatic brain injury, currently considered a singular event by the insurance industry and many health care providers, is instead the beginning of an ongoing process that impacts multiple organ systems and may cause or accelerate other diseases and disorders that can reduce life expectancy, according to research from the University of Texas Medical Branch at Galveston.

27 Aug 2010

Vanda Pharmaceuticals initiates tasimelteon Phase III clinical trial for Non-24-Hour Sleep Wake Disorder

Vanda Pharmaceuticals Inc., today announced it has initiated a Phase III clinical trial to evaluate tasimelteon in patients with Non-24-Hour Sleep Wake Disorder (N24HSWD), a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness.

26 Aug 2010

Aethlon Medical receives approval for Chronic HCV Infection treatment

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the Medanta Independent Ethics Committee (MIEC) at Medanta, The Medicity Institute (Medicity) has approved a treatment program entitled "Use of the Aethlon Hemopurifier in Treating Chronic HCV Infection in Combination with Standard of Care (SOC) Drug Therapy."

26 Aug 2010

Lotus Pharmaceuticals initiates R-Bambuterol Clinical Trial I on-schedule

Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China, announced today that it has entered R-Bambuterol Clinical Trial I on-schedule and is on-track to complete in six months. The studies will evaluate the safety and tolerability of the new drug as well as the biological activity by measuring responses in healthy volunteers.

26 Aug 2010

First World Congress on Ergothioneine to be held in Los Angeles, California in July 2011

OXIS INTERNATIONAL, INC. is proud to announce that it has initiated active planning for the First World Congress on Ergothioneine, to be held in Los Angeles, California in July 2011 (the specific date will be announced at a later date).

26 Aug 2010

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.

26 Aug 2010

Medical home model improves quality of healthcare, reduces cost: Geisinger study

Results of a Geisinger study published in the August 2010 edition of the American Journal of Managed Care show its advanced medical home model is capable of simultaneously improving the quality of healthcare and reducing the cost.

26 Aug 2010

RAND Corporation study reveals shortage of anesthesiologists, nurse anesthetists

A recent study from the RAND Corporation, one of the country's most trusted analytic organizations, finds a current shortage of 3,800 anesthesiologists and 1,282 nurse anesthetists. However, if current trends continue, a dramatic shortage of anesthesiologists and a significant surplus of nurse anesthetists are projected by 2020.

26 Aug 2010

Lack of awareness among referring physicians limits intervention in venous system: MRG

Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that although venous procedures are set to grow by more than 10% through 2013, a lack of awareness among referring physicians is a major roadblock in increased interventions in the venous system.

26 Aug 2010

EHE International endorses lifestyle medicine competencies

EHE International, a nationally recognized leader in preventive medicine, has endorsed the recently released set of physician competencies for prescribing lifestyle medicine. These competencies, suggested for primary care physicians, exemplify what EHE International has always practiced and encouraged.

26 Aug 2010

Neuralstem files IND with FDA for spinal cord stem cell Phase I clinical trial for chronic spinal cord injury

Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin a Phase I safety clinical trial for chronic spinal cord injury with its spinal cord stem cells. This multicenter Phase I safety trial will enroll a total of 16 long-term, or chronic, spinal cord injury patients, with an American Spinal Injury Association (ASIA) Grade A level of impairment, one-to-two years post-injury.

26 Aug 2010

FDA grants LFB's recombinant anti-CD20 monoclonal antibody orphan drug status for CLL

The recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug status for the treatment of Chronic Lymphocytic Leukemia (CLL). This approval from the FDA Office of Orphan Products Development was granted on August 6th, 2010.

26 Aug 2010

CFHR5 nephropathy linked to genetic mutation in innate immune system

A rare form of kidney disease linked to a genetic mutation in the innate immune system has been identified by researchers funded by the Wellcome Trust and the Medical Research Council.

26 Aug 2010

TRT receives patent rights for procedure of reattaching damaged soft tissue to bone

Tissue Regeneration Technologies, LLC (TRT), a Woodstock, Georgia medical technology company, recently received the rights to a new patent to bolster its SoftWave technology portfolio. The patent covers a method of reattaching damaged soft tissue to bone.

26 Aug 2010

Cornerstone Healthcare Plus REIT acquires $14.75M inpatient rehabilitation facility in Dallas

Cornerstone Real Estate Funds, and its strategic alliance partner and sub-advisor Servant Healthcare Investments, announced that the Cornerstone Healthcare Plus REIT has acquired an inpatient rehabilitation facility (IRF) for a purchase price of $14,750,000. The 42-bed, 40,000 square foot property is located in Dallas, Texas and is leased under a long-term lease to GlobalRehab LP.

26 Aug 2010

Vitamin D may be effective in preventing allergies in patients cystic fibrosis, asthma

Vitamin D may be an effective therapy to treat and even prevent allergy to a common mold that can cause severe complications for patients with cystic fibrosis and asthma.

26 Aug 2010

Researchers to test new plantain based food product to treat Crohn's disease

Crohn's is a condition that affects one in 800 people in the UK and causes chronic intestinal inflammation, leading to pain, bleeding and diarrhoea. Researchers are working with biotechnology company, Provexis, to test a new plantain based food product that could treat patients with the disease.

26 Aug 2010

Chronic News and Research

Second-hand smoke triggers complex inflammatory response

Luminex launches FDA-cleared xTAG Cystic Fibrosis 60 Kit v2 diagnostic test

Wall Street Journal reports on pharma's growing interest in emerging markets

Researchers recommend traumatic brain injury reclassification for additional funding

Vanda Pharmaceuticals initiates tasimelteon Phase III clinical trial for Non-24-Hour Sleep Wake Disorder

Aethlon Medical receives approval for Chronic HCV Infection treatment

Lotus Pharmaceuticals initiates R-Bambuterol Clinical Trial I on-schedule

First World Congress on Ergothioneine to be held in Los Angeles, California in July 2011

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

Medical home model improves quality of healthcare, reduces cost: Geisinger study

RAND Corporation study reveals shortage of anesthesiologists, nurse anesthetists

Lack of awareness among referring physicians limits intervention in venous system: MRG

EHE International endorses lifestyle medicine competencies

Neuralstem files IND with FDA for spinal cord stem cell Phase I clinical trial for chronic spinal cord injury

FDA grants LFB's recombinant anti-CD20 monoclonal antibody orphan drug status for CLL

CFHR5 nephropathy linked to genetic mutation in innate immune system

TRT receives patent rights for procedure of reattaching damaged soft tissue to bone

Cornerstone Healthcare Plus REIT acquires $14.75M inpatient rehabilitation facility in Dallas

Vitamin D may be effective in preventing allergies in patients cystic fibrosis, asthma

Researchers to test new plantain based food product to treat Crohn's disease

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News